Lexeo Therapeutics to Host Investor Event on Clinical Endpoints in PKP2-ACM

Bitget2026/10/19 11:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lexeo Therapeutics will host an educational investor event on PKP2 arrhythmogenic cardiomyopathy on Oct. 21, 2026, at 1 p.m. ET.
The discussion will focus on clinical assessments of arrhythmias used to evaluate disease burden and treatment response.
Speakers include Chief Medical Officer Narinder Bhalla and Cleveland Clinic physician-scientist Alessio Gasperetti.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190700PRIMZONEFULLFEED9848039) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lexeo Therapeutics to Host Investor Event on Clinical Endpoints in PKP2-ACM

You may also like

Crypto prices